Natalie Xu

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5‐fluorouracil, and cisplatin followed by radiotherapy and 5‐fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

Jerome C. Landry, Paul J. Catalano, Charles A. Staley et al. · Journal of Surgical Oncology · 2010 · 148 citations · Full text

Medicine, Oncology, Surgery +16

Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease?

Natalie Xu, Meng Wei Ho, Zuofeng Li et al. · American Journal of Clinical Oncology · 2013 · 42 citations

Medicine, Oncology, Radiation Oncology +17

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma

Darko Bosnakovski, Elizabeth T. Ener, Mark S. Cooper et al. · Oncogenesis · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacology +14

Toxicity Analysis of Dose Escalation From 75.6 Gy to 81.0 Gy in Prostate Cancer

Natalie Xu, Peter J. Rossi, Ashesh B. Jani · American Journal of Clinical Oncology · 2010 · 27 citations

Medicine, Oncology, Radiation Oncology +16

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer

Afshin Dowlati, Robert Chapman, Shanmuga Subbiah et al. · Investigational New Drugs · 2005 · 11 citations

Medicine, Oncology, Pharmacology +11